1.
|
Phase: Phase III Type: Treatment Status: Active Age: 20 to 75 Sponsor: Other Protocol IDs: WJTOG0101, NCT00139971
|
|
2.
|
Phase: Phase III Type: Treatment Status: Active Age: 20 to 80 Sponsor: Other Protocol IDs: HGCSG-CAD, NCT00209742
|
|
3.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: CPP276, NCT00207831
|
|
4.
|
Phase: Phase III Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: AERO-MB02, NCT00189631
|
|
5.
|
Phase: Phase III Type: Treatment Status: Active Age: 20 to 80 Sponsor: Other Protocol IDs: TMDU-BRI-CC-05-01, NCT00392899
|
|
6.
|
Phase: Phase III Type: Treatment Status: Active Age: 20 to 80 Sponsor: Other Protocol IDs: MCSGO-CCTG-0501, NCT00385970
|
|
7.
|
Phase: Phase III Type: Treatment Status: Active Age: 20 to 79 Sponsor: Other Protocol IDs: ICOG-CC01, NCT00497107
|
|
8.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 20 to 80 Sponsor: Other Protocol IDs: TMDU-TRICC0706, TRICC0706, NCT00660894
|
|
9.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: FEMH-94037, NCT00384800
|
|
10.
|
Phase: Phase II Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 950914, NCT00464919
|
|
11.
|
Phase: Phase II Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 940813, TTY-TU0510, NCT00519688
|
|
12.
|
Phase: Phase II Type: Treatment Status: Active Age: 70 and over Sponsor: Other Protocol IDs: UUH-ONC-0019, NCT00625352
|
|
13.
|
Phase: Phase II Type: Treatment Status: Active Age: 20 and over Sponsor: Other Protocol IDs: 376, NCT00855881
|
|
14.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis Status: Active Age: 20 to 75 Sponsor: Other Protocol IDs: TMDU-BRI-CC-05-02, BRI-CC-05-02
|